Limiting access to letrozole—is it justified?-Reference-Cited by-同舟云学术

Limiting access to letrozole—is it justified?

Published:2007-10 Issue:4 Volume:88 Page:779-780
ISSN:0015-0282
Container-title:Fertility and Sterility
language:en
Short-container-title:Fertility and Sterility

Author:

Tulandi Togas,DeCherney Alan H.

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Reproductive Medicine

Reference6 articles.

1. The outcome of 150 babies following the treatment with letrozole or letrozole and gonadotropins;Biljan;Fertil Steril,2005

2. A new era of ovulation induction;Holzer;Fertil Steril,2006

3. Fontana PG, Leclerc JM. Contraindication of Femara® (letrozole) in premenopausal women. Available at: http://www.ca.novartis.com/downloads/en/letters/femara_hcp_e_17_11_05.pdf

4. Catalog of teratogenic agents;Shepard,2001

5. Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate;Tulandi;Fertil Steril,2006

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of birth outcomes, congenital anomalies and neonatal complications of singletons born to infertile women treated with letrozole: A retrospective cohort study;Experimental and Therapeutic Medicine;2024-05-31

2. Perinatal outcomes and congenital anomalies associated with letrozole and natural cycles in single fresh cleaved embryo transfers: A single-center, 10-year cohort study;F&S Reports;2022-06

3. Oral Ovulogens in IUI and IVF;Principles and Practice of Controlled Ovarian Stimulation in ART;2015

4. Use of clomiphene citrate in infertile women: a committee opinion;Fertility and Sterility;2013-08

5. Dosage Optimization for Letrozole Treatment in Clomiphene-Resistant Patients with Polycystic Ovary Syndrome: A Prospective Interventional Study;Obstetrics and Gynecology International;2012